RemeGen Co., Ltd.
688331Biotechnology
CN¥93.62−3.32%As of Oct 29vs prior close
- Market cap
- $5B
- P/E (TTM)
- 9.3×
- P/E (FY1)
- 12.4×
- From 52W high
- −38.91%
- EPS (LTM)
- CN¥10.06
- Revenue (LTM)
- CN¥8B
- Net margin
- 72.71%
Nomior Score
54
Steady ProfileTop 41% of the scored universe
Growth44
Quality69
Value52
Momentum56
Resilience43
Growth
+61.62%revenue a year over 3 fiscal years
YE22 CN¥767.8MLTM CN¥8B
Connections
Revenue to profitYE25
22% of revenue became net profit, up 108 pts on a year.